ZHENG Hua-Guang,ZHANG Wei-Wei, ZHANG Long-You, WANG Rui-Qing, MENG Qing-Ying, LIU Xiao-Nan, DUAN Yun-Yun, LIU Ya-Ou,WANG Yong-Jun. Derivation and Validation of the Silent Brain Infarction Risk Score in the Healthy[J]. Chinese Journal of Stroke, 2020, 15(09): 999-1005.
[1] SMITH E E,SAPOSNIK G,BIESSELS G J,etal. Prevention of stroke in patients with silentcerebrovascular disease:a scientific statement forhealthcare professionals from the American HeartAssociation/American Stroke Association[J/OL].Stroke,2017,48(2):e44-e71[2019-12-19]. http://doi.org/10.1161/STR.0000000000000116.[2] DAS A S,REGENHARDT R W,VERNOOIJ MW,et al. Asymptomatic cerebral small vessel disease:insights from population-based studies[J]. J Stroke,2019,21(2):121-138.[3] REGENHARDT R W,DAS A S,LO E H,et al.Advances in lacunar stroke pathophysiology:areview[J]. JAMA Neurol,2018,75(10):1273-1281.[4] MEINEL T R,KAESMACHER J,ROTEN L,et al.Covert brain infarction:towards precision medicinein research,diagnosis,and therapy for a silentpandemic[J]. Stroke,2020,51(8):2597-2606.[5] VERMEER S E,KOUDSTAAL P J,OUDKERKM,et al. Prevalence and risk factors of silent braininfarcts in the population-based rotterdam scanstudy[J]. Stroke,2002,33(1):21-25.[6] PRABHAKARAN S,WRIGHT C B,YOSHITAM,et al. Prevalence and determinants of subclinicalbrain infarction:the Northern Manhattan Study[J].Neurology,2008,70(6):425-430.[7] DAS R R,SESHADRI S,BEISER A S,et al.Prevalence and correlates of silent cerebral infarctsin the Framingham Offspring Study[J]. Stroke,2008,39(11):2929-2935.[8] FEI H,ZHAI F F,WANG Q,et al. Prevalence andrisk factors of cerebral small vessel disease in aChinese population-based sample[J]. J Stroke,2018,20(2):239-246.[9] VERMEER S E,PRINS N D,HEIJER T D,et al.Silent brain infarcts and the risk of dementia andcognitive decline[J]. N Engl J Med,2003,348(13):1215-1222.[10] ANAND S S,FRIEDRICH M G,DESAI D,etal. Reduced cognitive assessment scores amongindividuals with magnetic resonance imaging-detected vascular brain injury[J]. Stroke,2020,51(4):1158-1165.[11] GUPTA A,GIAMBRONE A E,GIALDINI G,etal. Silent brain infarction and risk of future stroke:asystematic review and meta-analysis[J]. Stroke,2016,47(3):719-725.[12] CANNISTRARO R J,BADI M,EIDELMAN B H,et al. CNS small vessel disease:a clinical review[J].Neurology,2019,92(24):1146-1156.[13] NAKANISHI K,JIN Z,HOMMA S,et al. Nighttimesystolic blood pressure and subclinicalcerebrovascular disease:the CardiovascularAbnormalities and Brain Lesions(CABL)study[J].Eur Heart J Cardiovasc Imaging,2019,20(7):765-771.[14] CONEN D,RODONDI N,MÜLLER A,et al.Relationships of overt and silent brain lesionswith cognitive function in patients with atrialfibrillation[J]. J Am Coll Cardiol,2019,73(3):989-999.[15] NAM K W,KWON H M,JEONG H Y,et al. Serumhomocysteine level is related to cerebral small vesseldisease in a healthy population[J/OL]. Neurology,2019,92(4):e317-e325[2019-12-19]. https://doi.org/10.1212/wnl.0000000000006816.[16] SESHADRI S,WOLF P A,BEISER A S,et al.Association of plasma homocysteine levels withsubclinical brain injury:cerebral volumes,whitematter hyperintensity and silent brain infarctson volumetric MRI in the Framingham OffspringStudy[J]. Arch Neurol,2008,65(5):642-649.[17] LARSSON S C,TRAYLOR M,MARKUS HS,et al. Homocysteine and small vessel stroke:aMendelian randomization analysis[J]. Ann Neurol,2019,85(4):495-501.[18] CHAUHAN C,ADAMS H H H,SATIZABALC L,et al. Genetic and lifestyle risk factorsfor MRI-defined brain infarcts in a populationbasedsetting[J/OL]. Neurology,2019,92(5):e486-e503[2019-12-19]. https://doi.org/10.1212/wnl.0000000000006851.[19] 郑华光,刘晓楠,张蔚韡,等. 高血压与高同型半胱氨酸血症与静止性脑梗死的相关性分析[J]. 中国卒中杂志,2020,15(8):859-866.[20] ANAND S S,J TU J V,DESAI D D,et al.Cardiovascular risk scoring and magnetic resonanceimaging detected subclinical cerebrovasculardisease[J]. Eur Heart J Cardiovasc Imaging,2020,21(6):692-700.[21] WILLIAMS B,MANCIA G,SPIERING W,et al.2018 ESC/ESH Guidelines for the management ofarterial hypertension[J]. Eur Heart J,2018,39(33):3021-3104.[22] American Diabetes Association. Classification anddiagnosis of diabetes:standards of medical care indiabetes-2019[J/OL]. Diabetes Care,2019,42(Suppl1):S13-S28[2019-12-19]. https://doi.org/10.2337/dc19-s002.[23] KNUUTI J,WIJNS W,SARASTE A,et al. 2019ESC Guidelines for the diagnosis and managementof chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.[24] DING N,SANG Y Y,CHEN J S,et al. Cigarettesmoking,smoking cessation,and long-term risk of 3major atherosclerotic diseases[J]. J Am Coll Cardiol,2019,74(4):498-507.[25] WARDLAW J M,SMITH E E,BIESSELS G J,etal. Neuroimaging standards for research into smallvessel disease and its contribution to ageing andneurodegeneration[J]. Lancet Neurol,2013,12(8):822-838.[26] WESSLER B S,LAI YH L,KRAMER W,etal. Clinical prediction models for cardiovasculardisease:tufts predictive analytics and comparativeeffectiveness clinical prediction model database[J].Circ Cardiovasc Qual Outcomes,2015,8(4):368-375.[27] ALBA A C,AGORITSAS T,WALSH M,et al.Discrimination and calibration of clinical predictionmodels users’guides to the medical literature[J].JAMA,2017,318(14):1377-1384.[28] SPRINT Research Group,WRIGHT J T JR,WILLIAMSON J D,et al. A randomized trial ofintensive versus standard blood-pressure control[J].N Engl J Med,2015,373(22):2103-2116.[29] SPRINT MIND Investigators for the SPRINTResearch Group,WILLIAMSON J D,PAJEWSKIN M,et al. Effect of intensive vs standard bloodpressure control on probable dementia:a randomizedclinical trial[J]. JAMA,2019,321(6):553-561.